Pulmonx Net Profit Margin 2019-2024 | LUNG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Pulmonx net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Pulmonx net profit margin from 2019 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$9.2B
Inspire Medical Systems (INSP)	$5.7B
Hims & Hers Health (HIMS)	$5.5B
Enovis (ENOV)	$2.6B
Privia Health (PRVA)	$2.6B
IRhythm Technologies (IRTC)	$2.3B
Azenta (AZTA)	$2.2B
Omnicell (OMCL)	$2.1B
10x Genomics (TXG)	$1.7B
Clover Health Investments (CLOV)	$1.7B
Schrodinger (SDGR)	$1.5B
Phreesia (PHR)	$1.1B
Butterfly Network (BFLY)	$690M
Standard BioTools (LAB)	$596M
Talkspace (TALK)	$583M
Fulgent Genetics (FLGT)	$547M
Definitive Healthcare (DH)	$505M
Health Catalyst (HCAT)	$495M
TruBridge (TBRG)	$247M
SOPHiA GENETICS SA (SOPH)	$209M
American Well (AMWL)	$124M
EUDA Health Holdings (EUDA)	$112M
P3 Health Partners (PIII)	$76M
HeartBeam (BEAT)	$74M
111 (YI)	$52M
CareCloud (CCLD)	$46M
Outset Medical (OM)	$44M
SHL Telemedicine (SHLT)	$42M
Zepp Health (ZEPP)	$37M
Movano (MOVE)	$23M